Summary
Topical anti-inflammatory (cutaneous “vasoconstriction”) and systemic glucocorticoid (depression of plasma cortisol and changes in differential WBC count) potencies of the two glucocorticoids budesonide and beclomethasone dipropionate (BDP) were compared in human volunteers. After topical application, budesonide was 2–3 times more potent than BDP in inducing “vasoconstriction”. After oral administration, on the other hand, budesonide was 2–4 times less potent than BDP in depressing plasma cortisol and changing the total or differential WBC. After inhalation, too, significant differences in favour of budesonide were noted, but the divergence between the drugs was less pronounced. The improved relationship between the topical and systemic glucocorticoid effects of budesonide makes it a promising alternative for aerosol treatment in asthma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersson P, Edsbäcker S, Ryrfeldt Å (1982) In vitro biotransformation of budesonide, triamcinolonacetonide and hydrocortisone in liver and skin from man, rat and hairless mouse. J Steroid Biochem 16: 787–796
Armitage P (1974) Statistical methods in clinical research. Blackwell, Oxford
Björkander J, Formgren H, Johansson SÅ, Millquist E (1982) Methodological aspects on clinical trials with inhaled corticosteroids: Results of two comparisons between two steroid aerosols in patients with asthma. Eur J Respir Dis Suppl 122 (Vol 63) 108–117
Brattsand R, Thalén A, Roempke K, Källström L, Gruvstad E (1982) Influence of 16α, 17a-acetal substitution and steroid nucleus fluorination on the topical to systemic activity of glucocorticoids. J Steroid Biochemistry 16: 779–786
Brown MH, Storey G (1973) Beclomethasone dipropionate steroid aerosol in treatment of perennial allergic asthma in children. Br Med J 3: 161–164
Brown MH, Storey G, George WHS (1972) Beclomethasone dipropionate: A new steroid aerosol for the treatment of allergic asthma. Br Med J 1: 585–590
Brown MH, Storey G (1975) Treatment of allergy of the respiratory tract with beclomethasone dipropionate steroid aerosol. Postgrad Med J 51 (Suppl 4): 59–64
Buniva G, Dubini A, Sassella D (1979) Human bioassay of corticotropin-suppressing eosinopenic and hyperglycaemic potencies of deflazacort and prednisone. Curr Ther Res 26: 69–81
Claman HN (1975) How corticosteroids work. J Allergy Clin Immunol 55: 145–51
Clark THJ (1972) The effect of beclomethasone trpropionate delivered by aerosol in patients with asthma. Lancet 1: 1361–1364
Ellul-Micallef R, Hansson E, Johansson SÅ (1980) Budesonide A new corticosteroid in bronchial asthma. Eur J Respir Dis 61: 167–173
Finney DJ (1952) Statistical method in biological assay. Hafner, New York
Harris DM (1980) In: Topical steroid treatment for asthma and rhinitis. Clark THJ and Mygind N (eds) Clinical Pharmacology of Beclomethasone dipropionate. Baillere-Tindall, London, pp 34–47
Hartiala J, Uotila P, Nienstedt W (1979) Absorption and metabolism of intratracheally instilled cortisol and beclomethasone dipropionate in the isolated perfused rat lungs. Med Biol 57: 294–297
Martin LE, Tanner RJN, Clark THJ, Cochrane GM (1974) Absorption and metabolism of orally administered beclomethasone dipropionate. Clin Pharmacol Ther 15: 267–275
McKenzie AW, Stoughton RB (1962) Method for comparing percutaneous absorption of steroids. Arch Dermatol 86: 608–610
Mygind M, Hansen J (1973) Beclomethasone dipropionate aerosol effect on the adrenals in normal persons. Acta Allergol 28: 211–218
Place VA, Velazquez JG, Burdick KH (1970) Precise evaluation of topically applied corticosteroid potency. Arch Dermatol 101: 531–537
Rosenhall L, Lundquist G, Ädelroth E, Glennow C (1982) Comparison between inhaled and oral corticosteroids in patients with chronic asthma. Eur J Respir Dis Suppl 122 (Vol 63) 154–162
Ryrfeldt Å, Andersson P, Edsbäcker S, Tönnesson M, Davies D, Pauwels R (1981) Pharmacokinetics of a selective glucocorticoid, budesonide. Proceedings of the Annual Meeting of European Academy of Allergology and Clinical Immunology, Clermont-Ferrand, France 704–708
Ryrfeldt Å, Tönnesson M, Nilsson E, Wikby A (1979) Pharmacokinetics studies of a potent glucocorticoid (budesonide) in dogs by high performance liquid chromatography. J Steroid Biochem 10: 317–324
Scott M, Malmsten LÅ, Thelin J (1981) Effect on plasma cortisol level and urinary cortisol excretion, in helathy volunteers, after application of three different topical steroid ointments under occlusion. Acta Derm Venereol 61: 543–546
Thalén A, Brattsand R (1979) Synthesis and Anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity. Arzneim Forsch 29 (II), 11: 1687–1690
Toogood JH, Lefcoe NH, Haines DSM, Jennings B, Errington M, Baksh L, Chuang L (1977a) A graded doseassessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy 59: 298–308
Toogood JH, Lefcoe NH, Haines DSM, Chuang L, Jennings B, Errington N, Baksh L, Cauchi M (1978) Minimum dose requirements of steroid-dependent asthmatic patients for aerosol beclomethasone and oral prednisone. J Allergy 61: 355–364
Wyatt R, Waschek J, Weinberger M, Sherman B (1978) Effects of inhaled beclomethasone dipropionate and alternateday prednisone on pituitary-adrenal function in children with chronic asthma. N Engl J Med 299 (No.25): 1387–1392
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johansson, S.Å., Andersson, K.E., Brattsand, R. et al. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol 22, 523–529 (1982). https://doi.org/10.1007/BF00609625
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609625